Chi Hoon Maeng
No ORCID on file
· 1 paper in corpus
case-report
2020
BACKGROUND: Lenvatinib, a novel multi-target tyrosine kinase inhibitor, has been approved for treating differentiated thyroid cancer. Herein, we describe a rare case of acute pancreatitis that developed during lenvatinib treatment in a 65-y…